Is chemoprophylaxis necessary for all latent tuberculosis infection patients receiving IL ‐17 inhibitors? A cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is chemoprophylaxis necessary for all latent tuberculosis infection patients receiving IL ‐17 inhibitors? A cohort study

Published:2020-11 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Shu Dan¹^ORCID,Zhang Zhuying¹,Zhou Eray Yihui¹,Ma Xuzhu²,Zhao Yi¹

Affiliation:

1. Department of Dermatology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine Tsinghua University Beijing China

2. Department of General Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine Tsinghua University Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14512

Reference32 articles.

1. Organization W.H. WHO 2020(3)

2. Organization W.H. Global tuberculosis report 2018. Australasian Medical Journal 2018;6(2).

3. ESCMID study Group for Infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (soluble immune effector molecules [I]: anti‐tumor necrosis factor‐alpha agents);Baddley JW;Clin Microbiol Infect,2018

4. Pro- and anti-inflammatory cytokines in tuberculosis: A two-edged sword in TB pathogenesis

5. Altered expression of antigen-specific memory and regulatory T-cell subsets differentiate latent and active tuberculosis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN‐FRT expert consensus;Journal of the European Academy of Dermatology and Venereology;2024-08-16

2. Evaluation of serial QuantiFERON‐TB Gold in tube test results and tuberculosis infection status in patients with psoriasis receiving anti‐IL‐17 treatment (secukinumab and ixekizumab): Real‐world data from a tuberculosis‐endemic country;Australasian Journal of Dermatology;2024-07

3. Interleukin-17A Inhibitors in Patients with Psoriasis and Tuberculosis Infection: A 2-Year Prospective Study on Safety Without Preventive Treatment;Dermatology and Therapy;2024-03-14

4. Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study;American Journal of Clinical Dermatology;2024-01-24

5. Use of biologics in patients with psoriasis – A retrospective analysis based on real‐world data;Skin Research and Technology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3